U.S. Other Utilities Stock News

In April 2026, Microchip Technology expanded its reach and product capabilities through new distribution, manufacturing and collaboration agreements, alongside launching its dsPIC33AK256MPS306 Digital Signal Controllers featuring post-quantum cryptography for automotive, industrial, data center and AI server applications. Together, these moves strengthen Microchip’s role in secure, high-reliability embedded systems across automotive ADAS, defense and aerospace, and intelligent power and...

Wondering whether Brown & Brown is priced attractively right now, or if the recent share moves are a warning sign? This breakdown will help you size up the stock's current value with clear, grounded numbers. The share price most recently closed at US$68.82, with returns of 2.5% over 7 days, 0.7% over 30 days, an 11.3% decline year to date, and a 40.9% decline over the last year. The 3-year and 5-year returns sit at 15.4% and 42.5% respectively. These moves come against a backdrop of ongoing...

Recent performance snapshot Atlanticus Holdings (ATLC) has drawn fresh attention after a recent move in the share price, with the stock showing a mix of short term volatility and stronger performance over the past month and the past 3 months. See our latest analysis for Atlanticus Holdings. The recent pullback, with a 1 day share price decline of 2.05% to US$66.96, follows strong momentum including a 24.32% 30 day share price return and a 28.03% 1 year total shareholder return. This indicates...

Stock performance snapshot Cohu (COHU) has attracted attention after a strong run, with the share price at $39.37 and gains over the past day, week, month, and 3 months all in positive territory based on the provided returns. See our latest analysis for Cohu. The recent 1 month share price return of 36.32% and year to date share price return of 59.98% sit against a 1 year total shareholder return of 180.01%. This points to strong momentum building after a slower multi year record. If you are...

Engine’s expanded use of Salesforce (CRM) Agentforce 360 and Slack, with AI agents handling 50% of chat cases and cutting average handle time by 15%, gives investors a concrete example of Salesforce’s agentic model in production. See our latest analysis for Salesforce. Despite the Engine news and broader AI headlines helping sentiment in recent sessions, Salesforce’s 7 day share price return of 6.07% comes after a 30 day share price return of 7.21% and a year to date share price return of a...

Earnings surprise lifts interest in United Natural Foods stock United Natural Foods (UNFI) recently reported quarterly results, with revenue down 2.6% year on year and below analyst expectations, while EBITDA came in ahead of forecasts, a mix that has drawn fresh attention to the stock. See our latest analysis for United Natural Foods. The mixed earnings report appears to have reset expectations, with the stock posting a 17.0% 1 month share price return and a 40.6% year to date share price...

On 16 April 2026, Medline announced a new agreement to pilot Symbotic's AI-powered warehouse automation system at a U.S. distribution center in 2027, marking the first use of this technology in the healthcare supply chain. This move highlights how Symbotic's robotics platform is extending beyond retail into healthcare logistics, underscoring its flexibility across complex, high-stakes distribution networks. Next, we'll examine how entering healthcare logistics with Medline could reshape...

In recent days, analysts have projected year-over-year growth in Danaher’s earnings per share and revenue, while its Beckman Coulter and Cepheid units announced new infection-differentiation assays and expanded pathogen-identification collaborations in Europe and infectious disease research. Together, these developments highlight how Danaher’s diagnostics platforms are being equipped with faster, more informative tests that target antibiotic stewardship and complex infectious disease...

Event context and recent share performance Assurant (AIZ) has come into focus after recent share price moves, with the stock closing at $224.65. Short term returns are modestly positive, while performance over the past 3 months and year to date has been weaker. See our latest analysis for Assurant. The recent 1 month share price return of 3.37% contrasts with weaker 3 month and year to date share price returns. At the same time, a 1 year total shareholder return of 20.75% highlights...

Wondering if Citizens Financial Group at around US$64.41 is still offering value after a strong run, or if most of the opportunity is already priced in. The stock has seen a 0.9% decline over the last 7 days, a 12.8% return over 30 days, 8.5% year to date, 88.3% over 1 year and 83.9% over 5 years, which points to meaningful shifts in how the market is viewing the bank. Recent coverage has focused on Citizens Financial Group as part of broader discussions around U.S. bank stocks, capital...

Why Corcept Therapeutics (CORT) Is Back on Investors’ Radar Corcept Therapeutics (CORT) has drawn fresh attention after presenting final overall survival data from its pivotal Phase 3 ROSELLA trial and securing FDA approval for Lifyorli in platinum-resistant ovarian cancer. See our latest analysis for Corcept Therapeutics. The recent FDA approval of Lifyorli and its inclusion in NCCN guidelines appear to have coincided with strong momentum, with a 31.2% 1 month share price return and a 26.6%...

Ionis Pharmaceuticals: Recent Returns and Business Profile Ionis Pharmaceuticals (IONS) has seen mixed recent returns, with the stock showing a small decline over the past week and gains over the past month. Year to date, performance remains slightly negative. Over the past year, Ionis has delivered a 1.65% total return, with longer horizons showing higher cumulative figures over the past 3 years and past 5 years. The company last closed at US$75.26, giving it a market value of about...

In recent days, GigaCloud Technology Inc. has attracted fresh attention after Jim Cramer praised the company on Mad Money, highlighting his positive meeting with the CEO and describing the stock as inexpensive, while Zacks assigned it a top rating supported by upbeat earnings estimate revisions. This combination of high-profile media endorsement and favorable analyst sentiment is drawing new focus to GigaCloud’s B2B ecommerce platform for large-parcel cross-border trade. Now, we’ll examine...

Mondelez International (MDLZ) is in focus after releasing its 2025 sustainability progress report and highlighting work with Celleste Bio on cell cultured cocoa butter, alongside fresh shareholder pressure on plastics packaging and board leadership. See our latest analysis for Mondelez International. At a share price of US$57.07, Mondelez has seen a 6.37% year to date share price return, while its 1 year total shareholder return of 12.40% and 3 year total shareholder return of 12.63% indicate...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Investors may be wondering whether Chevron, at around US$188 per share, still offers value or if most of the easy gains are already behind it. The stock has recorded a 20.7% return year to date and a 42.6% return over the last year, alongside shorter term moves such as a 1.2% decline over 7 days and a 5.0% decline over 30 days. These recent moves sit against an ongoing flow of company and industry updates that continue to shape expectations around energy prices, long term capital spending,...

If you are wondering whether Doximity's current share price still reflects its long term potential, the recent moves in the stock make a closer look at value hard to ignore. The stock last closed at US$24.25, with a 14.6% gain over the past 7 days, a 2.6% decline over 30 days, and year to date and 1 year returns of 44.0% and 54.4% declines respectively. These swings have kept attention on how the market is reassessing expectations for Doximity, with recent headlines continuing to frame the...

Vertical Aerospace (NYSE:EVTL) has drawn fresh attention after completing a two-way piloted transition flight in its full-scale tiltrotor eVTOL. This is a key step that validates its electric air taxi concept under civil aviation oversight. See our latest analysis for Vertical Aerospace. The successful transition flight has arrived alongside sharp short term share price momentum, with a 1 day share price return of 25.56% and 7 day return of 45.22%. However, this sits against a weaker 90 day...

Wondering if Adams Diversified Equity Fund is still good value after its recent run, or if you might be late to the story? The share price last closed at US$23.79, with returns of 1.1% over 7 days, 4.7% over 30 days, 2.3% year to date, 42.5% over 1 year, 104.2% over 3 years and 109.8% over 5 years. Recent coverage has focused on how Adams Diversified Equity Fund fits into the broader Capital Markets space and what that means for investors weighing income, diversification and liquidity. This...

Clearway Energy is asking stockholders to approve a plan to consolidate its public share classes into a single share class. The company is seeking this approval at an upcoming stockholder meeting as part of an effort to simplify its equity structure. Proxy advisory firm ISS has recommended that investors vote "FOR" the proposed share class unification. For investors tracking NYSE:CWEN.A, the proposal comes as Clearway Energy trades at a share price of $39.98 and carries a value score of 3...

LyondellBasell Industries recently drew attention as Jim Cramer highlighted it in a list of companies linked to the Iran conflict, while Citigroup reiterated a positive analyst stance, and the company also published its 2025 Sustainability Report detailing operational performance and safety outcomes. The report underscored LyondellBasell’s progress in circular and low‑carbon polymers, including ongoing construction of its first commercial‑scale catalytic chemical recycling facility in...

RBC Capital Markets’ decision to lift its 2026 funds from operations estimate for American Healthcare REIT (AHR) to US$2.04 per share, tied to a higher investment pace, has put fresh attention on the stock. See our latest analysis for American Healthcare REIT. The latest analyst revision comes as American Healthcare REIT trades at US$50.58, with a 1-day share price return of 2.22% and a 7-day share price return of 2.99%. The 1-year total shareholder return of 69.18% points to strong momentum...

If you are wondering whether Palo Alto Networks is fairly priced or if the market is missing something, starting with a clear view of its current valuation can help ground your decision. The stock last closed at US$166.97, with returns of around 0% over 7 days, a 1.3% decline over 30 days, a 6.9% decline year to date, and a 0.4% decline over the past year. The 3 year and 5 year returns stand at 73.7% and 184.0% respectively. Recent headlines around Palo Alto Networks have focused on its role...

In early April 2026, the American Hospital Association named Rubrik a Preferred Cybersecurity Provider, giving nearly 5,000 member hospitals access to its cyber resilience bundle, including identity recovery, Microsoft 365 protection, ransomware training, and a five-year financial impact assessment. This endorsement strengthens Rubrik’s role in safeguarding critical healthcare infrastructure, tying its data security platform directly to operational continuity for hospitals facing rising...